A name brand version of a cheap and widely available anti-inflammatory steroid will be assessed by the European Medicines Agency to determine if it can be recommended as a treatment option for adult patients suffering from Covid-19. Its use was also being researched by the Dutch Medicines Evaluation Board, according to AD, which previously evaluated remdesivir, an anti-viral intravenous drug …
